Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Choice of dialysis modality among patients initiating dialysis: results of the Peridialysis study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased incidence and improved prognosis of glomerulonephritis: a national 30-year study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A primer on metabolic memory: why existing diabesity treatments fail

    Research output: Contribution to journalReviewResearchpeer-review

  4. Musculoskeletal pain reported by mobile patients with chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Fatal case of hospital-acquired hypernatraemia in a neonate: lessons learned from a tragic error

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diabetes increases the risk of bone fractures in patients on kidney replacement therapy: A DANISH national cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High bone mineral density in lifelong trained female team handball players and young elite football players

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Arterial calcification is associated with cardiovascular mortality in dialysis patients. Active matrix Gla protein (MGP) is a vitamin K-dependent inhibitor of arterial calcification. Elevated plasma concentrations of inactive MGP, i.e. dephosphorylated-uncarboxylated MGP (dp-ucMGP), are prevalent in dialysis patients. MGP inactivity might contribute to arterial calcification. We investigated whether vitamin K supplementation had an effect on arterial calcification in chronic dialysis patients.

Methods: In a 2-year, double-blind, placebo-controlled intervention trial, 48 dialysis patients were randomized to vitamin K [menaquinone-7 (MK-7), 360 µg daily] or placebo. MK-7 in serum and dp-ucMGP in plasma were used to assess vitamin K status. Carotid-femoral pulse wave velocity (cfPWV) and scores of coronary arterial calcification (CAC) and abdominal aortic calcification (AAC) were used to assess arterial calcification.

Results: Thirty-seven participants completed Year 1, and 21 completed Year 2. At Year 2, serum MK-7 was 40-fold higher, and plasma dp-ucMGP 40% lower after vitamin K supplementation compared with placebo {mean dp-ucMGP difference: -1380 pmol/L [95% confidence interval (CI) -2029 to -730]}. There was no significant effect of vitamin K supplementation on cfPWV [mean difference at Year 2: 1.2 m/s (95% CI -0.1 to 2.4)]. CAC Agatston score increased significantly in vitamin K supplemented participants, but was not significantly different from placebo [mean difference at Year 2: 664 (95% CI -554 to 1881)]. AAC scores increased in both groups, significantly so within the placebo group at Year 1, but with no significant between-group differences.

Conclusions: Vitamin K supplementation improved vitamin K status, but did not hinder or modify the progression of arterial calcification in dialysis patients.

Original languageEnglish
JournalClinical kidney journal
Volume14
Issue number9
Pages (from-to)2114-2123
Number of pages10
ISSN2048-8505
DOIs
Publication statusPublished - Sep 2021

    Research areas

  • chronic kidney disease, coronary arterial calcification, menaquinone-7, pulse wave velocity

ID: 67500744